Welichem Biotech appoints Ryan Zeng to Board of Directors

– CANADA, BC – Welichem Biotech Inc. (TSX-V: WBI), announced today that Ryan B. Zeng has been appointed as a new director of the Company effective immediately.

Mr. Zeng has been serving as a senior manager of T&T Supermarket in Richmond, British Columbia since 2008. He has extensive experience and knowledge in computer sciences, company operation and management from various industries including technology and supermarket companies over more than 15 years. Mr. Zeng obtained his Bachelors Degree in Computer Science from Jilin University (China) in 1998.

The Company also announced today that Mr. James Dai has resigned as a director of the Company effective January 2, 2014. The Company has valued the contribution of Mr. Dai as a director of the Company and Chair of the Audit Committee over the past year and wishes his success in his future endeavors.

About Welichem Biotech Inc.

Welichem Biotech Inc. is a publicly-traded biotechnology company developing therapeutic drugs in the fields of autoimmune diseases and cancer.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Comments are closed.